Contents
From the Director 4
Meet the Team 6
Visitingresearchersandaffiliates 9
PhD students 11
Strategic activities 12
Internationalisation 13
Worldclassenvironment 15
Innovative engagement 16
Highlightsof2016 18
Research 20
Research themes 21
Projectsawardedin2016 22
Ongoingprojects 23
Projectscompletedin2016 26
NIHR CRSU 27
Aresearcher’sperspective–CaoimheRyan 28
TeachingandSupervision 30
ContinuingProfessionalDevelopment 32
Publications 34
Presentations 37
MembershipofExpertBodies 40
3
Welcometoourfifthannualreport,which provides an overview of themanyaccomplishmentsthat
wecelebrateattheHealthEconomicsandHealthTechnologyAssessment(HEHTA)ResearchGroupin2016.Thispastyear,myfirstinmynewroleasDirector,hasbeenanotherhighlysuccessfulandproductiveyearfortheteam.Amongourresearchandteachinghighlights,isourgrowinginternationalcollaborationsandpublicengagementinitiatives.Ihopeyouwillenjoyreading about our new projects funded by theEuropeanCommissiononevaluationsofcomplexclinicalandpopulationhealthinterventions,andourpublicengagementexerciseonprioritisinghealthcarefundingallocations.
OneofthecelebrationsIwouldliketohighlight,isthepromotionofourDeputyDirector,DrEmmaMcIntoshtofullProfessorofHealthEconomics.DrMcIntoshjoinedHEHTAin2011,andhasbeendedicatedtoshaping HEHTA into a team that produces high-qualityworkwithinasupportingandnurturingenvironment.Overtheyears,shehasundertakenhighlyimpactfulresearchandsuccessfullyraisedHEHTA’sprofileinHealthEconomicsofPublicandPopulationHealth.Thisisamajorpersonalachievement,andawell-deservedrecognition of her contribution to HEHTA and theUniversity.
In2016,wealsomarktheintroductionof an exciting new research theme – ‘EconomicsofPrecisionMedicine’.Thisresearchthemecomplementsoneofthe
achievementsofourCollegeofMedical,Veterinary & Life Sciences in becoming akeyplayerinaScottish“globalcentreofexcellence”inprecisionmedicine.WearedelightedtowelcomeProfessorNeilHawkins,whojoinedusasProfessorofHealthTechnologyAssessment,toleadthisresearchtheme.ProfessorHawkins’sresearchfocusesonmethodologicaldevelopmentofevidencesynthesisanddecisionanalyticalmodelling,andintheirapplicationtoprecisionmedicineandearlystagehealthtechnologyassessment.Welookforwardtoreportingactivitiesfromthisresearchthemenextyear.
5
DIRECTOR
OliviaWu ProfessorofHealthTechnologyAssessment
DEPUTY DIRECTOR
Emma McIntosh ProfessorofHealthEconomics
PROFESSORS
Andrew Briggs WilliamR.LindsayChairinHealthEconomics
NeilHawkins ProfessorofHealthTechnologyAssessment
READER
Jim Lewsey
LECTURERS
KathleenBoydHannahHesselgreavesClaudiaGeue
RESEARCHERS
CamillaBabaWillingsBothaJanetBouttellNickiBoyerManuelaDeiddaEleanorGrieveRobert HeggieNicolaMcMeekinMinnie ParmiterZahidulQuayyumMohsen RezaeihemamiJoseAntonioRoblesZuritaCaoimhe RyanMiranda TrevorYiqiao Xin
PHD STUDENTS
YuliaAnopaGiorgio Ciminata Tadesse Gebrye CiaranKohli-LynchPattaraLeelahaverongClaireWilliams
VISITING RESEARCHERS
Shawn HsiehBrunoSalgadosRiveros CarlosWong
Meet the Team
6
AFFILIATES
Houra HaghpanahanPeterMcMeekin
HONORARY STAFF
HenryGlickKaren RitchieJames Robinson
ADMINISTRATORS
MoiraAitkenCarolineCecilJennieClarkAliedaMcKinney
7
In2016wewelcomedtotheteam...
ManuelajoinedHEHTAasaResearchAssociate,workingontwoprojects.Thefirstoneisabouttheeconomicevaluationofacomplexinterventiononsedentarybehaviourandphysicalactivityalongsideamultinationalrandomisedcontrolledtrial(RCT).Thesecondoneconcernseconomicevaluationofa means-tested voucher directed towards pregnant womenandmothersofchildrenunderfour.PriortojoiningHEHTAManuelaheldpositionsinacademia(UniversityofCagliariandUniversityofBolzano)andininternationalinstitutions(EuropeanCentralBankandEuropeanCommissionJointResearchCentre).Shehasworkedinarangeofareas,includinghealthtechnologyassessment,publicpolicyevaluation,households’economics,andtelemedicineandtelehealthsystems.
NeilisournewProfessorofHealthTechnologyAssessment(HTA)atHEHTA.HehasextensiveexpertiseinHTA,withparticularfocusonevaluationofearlystagetechnologies,precisionmedicine,evidencesynthesisanddecisionanalyticalmodelling.NeilwillleadanewresearchthemeinHEHTA,‘EconomicsofPrecisionMedicine’,developedtocomplementtheCollegeofMedical,VeterinaryandLifeSciences(MVLS)leadingpositioninprecisionmedicine.PreviouslyhewasaReaderattheLondonSchoolofHygieneandTropicalMedicine,andVicePresidentleadingtheglobalHealthEconomicspracticeatICONplc.HeisaregularadvisortopharmaceuticalandbiotechindustriesaswellastheNationalInstituteofHealthandCareExcellence(NICE)ScientificAdviceProgramme.
Joseisworkingoneconomicevaluationalongsideclinicaltrialsinvolvingtreatmentsandinterventionsindifferentcardiovasculardiseases,mentalhealthandcancer.HeholdsaMaster’sdegreeinEconomicsandWelfareEvaluationandPhDinEconomicsfromPablodeOlavideUniversity(Spain).José’sPhDthesisfocussedontheapplicationofpsychologytotheanalysisofeconomicdecisionsinthedomainofhealth.AsaPhDstudenthewasalsoavisitingresearcheratYunusCentreforSocialBusinessandHealthatGlasgowCaledonianUniversityandintheDepartmentofEconomicsattheUniversityofAlicante.Josehasworkedinacademiaandinotherpublicorganizations for over eight years combining research andteaching.
Caoimhe joined HEHTA as a qualitativeResearchAssociate,workingprimarilyonthequalitativepost-trialcomponentoftheCancerandVenousAccess(CAVA)trial.CaoimhecompletedaPhDinSocialPsychologyattheUniversityofStAndrews,whichinvestigatedsocialidentityandrepresentationingrassrootsanti-deportationcampaigns.Priortoherdoctoraltraining,sheworkedontwoconsecutiveChiefScientistOffice(CSO)projectsattheUniversityofStirlingandtheUniversityofStrathclydeinvestigatingpsychologicalfactorsassociatedwithsuicidalbehaviourandrepeatedself-harm.CaoimhealsohasanMScinSocialandCulturalPsychologyfromtheLondonSchoolofEconomics.
Manuela Deidda
Jose Antonio Robles-Zurita
Caoimhe Ryan
Neil Hawkins
8
VisitingResearchersandAffiliates
WewelcomedDrCarlosWong,Research Assistant Professor of theDepartmentofFamilyMedicineand Primary Care at the University ofHongKong.Carlos’sresearchinterestsarepatient-reportedoutcomemeasurementincludingqualityoflifeandhealthservicesresearch,particularlyretrospectiveadministrative database research and cost-effectiveness analysisofhealthcareinterventions.Carlosspenttwomonthswithus,andworkedontworesearchprojects,oneevaluatingthecost-effectivenessanalysisofrenalreplacementtherapyamongend-stagerenaldiseasepatientsinHongKong,andasecondexploringincrementalcosteffectivenessratio(ICER)thresholdsindecisionstoacceptemerginghealthtechnologyinHongKong.
HourajoinedHEHTAinMay2016asapart-timeresearcher,toworkasan econometrician on a CSO funded study to investigate the impact of tobaccocontrolMassMediaCampaignsonquittingbehaviour,smokingprevalenceandsmoking-relatedhealthoutcomesapplyingtimeseriesanalysis.Hourareceived a BSc degree and an MSc degree in Economics from Shahid Beheshti University in Iran before completingherPhDinEconomicsattheUniversityofLeicesterinJuly2015.HermainresearchinterestsareinHealthEconomicsandAppliedEconometrics.ShejoinsHEHTAfull-timeinJanuary2017.
Bruno Riveros is a visiting postgraduate research student from Brazil.HeisworkingonhisPhDwhichfocusesontheefficiencyofdifferentstrategiestotreatobesity/overweight.Todothis,heisadoptingaScottishCardiovascularDiseasesPolicyModeltotheBraziliansetting.Inparallel,heisdevelopingaconceptualmodelforotherHEHTAprojectscurrentlyinprogress.
PingHsuan(Shawn)Hsiehjoinedus as a visiting researcher for six months.ShawnhasanMScinTransdisciplinaryLongTermCareandaBScinPharmacy.DuringhistimewithHEHTA,heworkedonaresearchprojectonscreeningforhepatitisBandCinfections.HealsoengagedinlearningmethodologicalapproachestoHTA.
Peter joined HEHTA as a visiting Fellow.Afterstudyingeconomicsasanundergraduate,heobtainedanMScinHealthEconomicsfromYorkUniversity,beforeaPhDinHealthEconomicsfromNewcastleUniversity.Hehasbeenaco-applicantonseverallargeNIHRgrants.Hisresearchinterestsincludeemergencymedicine,transformationandchangeintheNHS,anddecisionmodelling.PeterisaFellowoftheHigherEducationAuthority.
Carlos Wong
Bruno Salgados Riveros
Ping Hsuan (Shawn) Hsieh
Houra Haghpanahan
PeterMcMeekin
9
…and we said goodbye to
Minnie Parmiter was with HEHTA for just over a year and workedwithEleanorGrieveoneconomicevaluationswithintheGlobalHTAtheme.
MirandaTrevorjoinedHEHTAin2014asatraineeresearcher,andhaslefttocommencehermedicalstudiesattheUniversityofNewcastle.
ZahidQuayyumwaswithHEHTAfortwoyears,workingonanumberofprojectsincludingCULPRIT-SHOCK.ZahidiscurrentlyattheBlizardInstitute,QueenMary,UniversityofLondon.
Minnie Parmiter Zahidul Quayyum
Miranda Trevor
10
PhD StudentsSubmitted in 2016
Camilla Baba ‘Valuing the health and wellbeing aspects of community empowerment using economic evaluation techniques’Supervisors: Emma McIntosh, Carol Tannahill (external)
Willings Botha‘Economics of forestry based health interventions’Supervisors: Andrew Briggs, Richard Mitchell (external)
Current students
Yulia Anopa‘Economics of paediatric caries prevention’Supervisors: Emma McIntosh, Lorna Macpherson (external)
Janet Bouttell‘Methods of early health technology assessment in precision medicine’Supervisors: Andrew Briggs, Neil Hawkins
Nicki Boyer‘Economic Evaluation of population health interventions’Supervisors: Emma McIntosh, Kathleen Boyd
Giorgio Ciminata‘Cost-effectiveness of new anticoagulant drugs using real world data within the Scottish population’Supervisors: Olivia Wu, Claudia Geue, Peter Langhorne (external)
Shadrach Dare‘A retrospective cohort study of the risk factors for neonatal sepsis and other pregnancy related adverse outcomes in Ghana’Supervisors: Danny Mackay (external), Jill Pell (external), Hannah Hesselgreaves
Karl Ferguson‘Diagram based analysis of causal systems for understanding the causes of alcohol problems’Supervisors: Jim Lewsey, Mark McCann (external), Danny Smith (external)
Ben Fulton‘Quantitative research of patient preferences and perceptions of precision medicine in Oncology’Supervisors: Robert Jones (external), Emma McIntosh, James Paul (external)
Tadesse Gebrye‘Cost-effectiveness analysis and modelling the lifetime costs and benefits of health behaviour interventions on Diabetes (Type 2)’Supervisors: Emma McIntosh, Kathleen Boyd
Eleanor Grieve‘A Methodological Approach for Evaluating the Impact of Health Technology Assessment’Supervisors: Andrew Briggs, Olivia Wu, Hannah Hesselgreaves
Ciaran Kohli-Lynch‘Primary prevention of cardiovascular disease in disadvantaged populations: a comparison of modelling methods in the UK and the US’Supervisors: Andrew Briggs, Kathleen Boyd
Pattara Leelahavarong‘Development and validation of alcohol use disorder prediction model for monitoring and evaluation of alcohol consumption control programmes in Thailand’Supervisors: Andrew Briggs, Jim Lewsey
Ana Cristina Perez‘Fatigue and dyspnoea in heart failure: insights from two large randomised clinical trials’Supervisors: John McMurray (external), Jim Lewsey
Yiqiao Xin‘Impact of variation of economic evaluation methods on the cost-effectiveness result: a case study of deep brain stimulation (DBS) in Parkinson’s’Supervisors: Emma McIntosh, Jim Lewsey
Claire Williams‘Demonstrating the potential of multi-state survival models for enhancing epidemiological and health economic modelling’Supervisors: Jim Lewsey, Andrew Briggs, Danny Mackay (external)
11
ReflectingtheUniversityofGlasgowstrategy:tobringinspiringpeopletogetherandcreateaworld-classenvironmentforlearningandresearch,empoweringstaffandstudentsaliketodiscoverandshareknowledgethatcanchangetheworld.
Strategic Activities
12
Bringinspiringpeopletogether-connectwiththeworldthroughinternationalisation
HEHTAinvestigatorsarecollaboratingonseveralinternationalprojects.HerewehighlightthreeEuropeanCommissionprojects.
SITless: Exercise Referral Schemes enhanced by Self-Management Strategies to battle sedentary behaviourFunder: European Union, Horizon 2020 Research and Innovation Programme
TheSITlessstudyisamulti-national,multi-centre,three-armrandomisedclinicaltrialaimingtoinvestigatethelong-termeffectsofacomplexinterventiononsedentarybehaviourandphysicalactivityinacommunity-dwellingolderpopulation.Theinterventionisbasedonexistingexercisereferralschemes(ERS)enhancedbyasocialcognitivegroupinterventiononself-managementstrategies(SMS).Thelong-termcost-effectivenessofajointinterventionofERSandSMSisevaluatedagainsttwoalternatives-ERSaloneandusualcare.
The costs of providing ERS enhanced by SMS are identifiedfromnationalhealthserviceandpersonalsocialservicesperspectivesalongsidepotentialcostimpactsincludinghospitalisations,accidentandemergencyvisits,andappointmentswithhealthprofessionals.Outcomesincludeself-reportedhealthrelatedQualityAdjustedLifeYears(QALYs)whichareobtainedusingtheEQ-5DEuroQolinstrument(EQ-5D)aswellasthenewlydevelopedcapabilitiesmeasureofoutcomesforolderpeople,theICECAP-Oinstrument.Country-specifictariffsarealsoused.Thewithin-trialeconomicevaluationresultsarecombinedwithevidencefromtheliteraturelinkingshort-termandlongertermoutcomes to produce a cost-effectiveness decision analyticmodel,usingaMarkovmodel.Adetailedsensitivityanalysisexploreshowcost-effectivenessvarieswithinalltherealisticrangesofcostsandoutcomes.
Thestudyalsoconsiderstheadditionalchallengesrelatedtotheevaluationofcomplexpublichealthinterventionsofthistypeaswellastothemulti-countrynatureoftheintervention.HEHTA Principal Investigator: Professor Emma McIntosh
PATHway: Technology enabled behavioural change as a pathway towards better self-management of CVDFunder: European Union, Horizon 2020 Research and Innovation Programme
The PATHway Consortium comprises eight partners from acrossEurope.PATHwayproposesanovelapproachtoCardiacRehabilitation(CR)aimedatempoweringpatientstomoreeffectivelyself-managetheirCardiovascularDisease(CVD).Thehealtheconomicanalysiscombinesandevaluateshealthoutcomesand resource use consequences of the PATHway interventiontodetermineincrementalcost-effectivenessofPATHwaycomparedwithusualcare.Thewithin-trialanalysisfocusesonthetrialperiodofsixmonthsandanextrapolationoftrialresultswillallowustodeterminelifetimecostsandoutcomesandlong-termcost-effectivenessbeyondthetrialperiod.
Resourceutilizationincludesthecostofdeliveringtheprogramme(eitherPATHwayorusualcare,asinterventioncost),thehealthservicecosts(healthcarecosts),thecostsfallingontheparticipants(directnon-medicalcosts)andtheproductivityeffectsintermsofpatients’employment(lostproductivity).Health-relatedoutcomemeasuresincludephysicalactivityandqualityoflife(EQ-5DEuroQolinstrument).Alownumberofclinicaleventsisanticipatedtobeobservedduringthetrialperiodsothatparameterestimateswillneedtobeobtainedfromtheepidemiologicalliteraturethatlinkschangesinexercisecapacitywiththeprobabilityofexperiencingadverseclinicalevents.
13
LinkingchangesinexercisecapacityandriskprofilestorecurrentCVDeventsandCVDmortalitywewillestimatethecostperQALYassociatedwithPATHwayandidentifywhetherthecostsrelatedtoPATHwayareoffsetbyareductioninclinicaleventsandrelatedhospitalisationsinthelongterm.
TheEuropeanCommissionreviewinMarch2016reportedveryfavourableprogressinyearone.TheCommissionreportedthattheconsortiumisclearlyadvancingstate-of-the-artandprovidinganexampleforuser-centreddesignthatcanbeamodelforotherEUprojects.HEHTA Principal Investigator: Professor Andrew Briggs
CULPRIT-SHOCK: Multivessel versus culprit lesion only percutaneous revascularization in patients with acute myocardial infarction complicated by cardiogenic shock Funder: European Union, 7th Framework Programme
The CULPRIT-SHOCK Consortium consists of 17 partnersfrom11differentEUmemberstatesaswellasSwitzerland.Cardiogenicshockcomplicatingacutemyocardialinfarction(AMI)representsamajorEuropeanhealthcareconcernwithmortalityratesbetween40%and70%.Theclinicianisfacedwiththedecisiontoeitherinterveneonlyontheculpritlesionacutelyresponsiblefortheinitiationofcardiogenicshock,ortotreatadditionallesionsconsideredhemodynamicallysignificantbutnotacutelytriggeringtheshockcascadeaswell.TheaimoftherandomizedCULPRIT-SHOCKtrialistocompareimmediatemultivesselPercutaneousCoronaryIntervention(PCI)versusculpritlesiononlyPCIinpatientswithAMIcomplicatedbycardiogenicshock.
Theeconomicevaluationwillcomparethetwointerventionsanalysed:1)culpritvesselonlyPCIwithpotentiallysubsequentstagedrevascularization,and;2)immediatemulti-vesselrevascularizationbyPCI.Theeconomicevaluationcomprisesbothcost-effectivenessanalysis(CEA)andcost-utilityanalysis(CUA).TheCEAwillusetheoutcomemeasuresof30-daymortalityandrenalfailure.QALYswillbeusedfortheCUA.Thewithin-trialanalysiswillprovideestimatesofcostperlifesavedat30-dayandinoneyear,andestimatesofhealth-relatedqualityoflife.Thelong-termanalysiswillcombinewithin-trialinformationandevidencefromtheliteraturetopopulatethepre-trialmodelthatwillallowustocomputeincrementalQALYs.Themodelling-basedanalysiswillprovideexpectedcostsandhealthoutcomes,andincrementalcost-effectivenessratiooverthelifetimeforthecohortofpatientsincludedinthetrial.Theeconomicevaluationwillincludehealthsystemsandsocietalperspectives,suchasinterventioncosts,medication,andproductivityloss.Thecost-effectivenessanalysiswillbefromtheperspectiveofeachcountry’snationalhealthservices.
Uponcompletion,CULPRIT-SHOCKwillbethelargestrandomizedcontrolledclinicaltrialinpatientswithcardiogenicshockeverconductedandwillinformpatients,healthcareproviders,anddecision-makersaboutwhichpercutaneousrevascularizationstrategyismosteffective.HEHTA Principal Investigator: Professor Andrew Briggs
14
Create a world-class environment for learningandresearchAcrosstheworld,governmentsareincreasinglyestablishingHTAprogrammesandagencies.Thereforethere is an increasing need to train HTA practitioners to informthedecisionmakingprocess.Inresponsetothis,HEHTAdevelopedapostgraduateprogrammeandourMScinHTAranforthefirsttimein2013.
Twoyearsagowedevelopedourprogrammetobedeliveredasonlinedistancelearning(ODL)toincreaseourglobalreachandtoofferflexibilitytothosewhowanttoremainintheiremploymentbutwouldliketoup-skillatthesametime.OurpostgraduatetaughtcoursesprovideasolidgroundinginallthemajordisciplineswithinthefieldofHTA.ThisisuniquewithinScotland,andisoneoffewsuchprogrammesworldwide.Ourteamareworld-classexpertsintheirfields,andareactivenotonlyinresearchandteaching,butalsoinHTAdecision-makingatanationallevel(e.g.throughNICEandScottishHealthTechnologiesGroupatHealthcareImprovementScotland).
Ourteachingisresearch-led.Thecourseshavebeendevelopedtoreflectthelatestacademicresearchandup-to-datechallengesinHTAdecision-making.Students gain a comprehensive understanding and hands-onexperienceoftheinterconnecteddisciplinesthatarecoretoHTA.Theseincludehealtheconomics,statistics,evidencesynthesis,modellingandpatient-reportedoutcomemeasures.Inacademicyear2016-17wehave17students.
MSc HTA:requiresatotalof180creditstobecompletedoverthecourseofthedegree.60creditsfrom3corecourses,60creditsfromoptionalcourses,60creditfromaresearchproject.
PgDip HTA:requiresatotalof120creditstobecompletedoverthecourseofthedegree.60creditsfrom3corecourses,60creditsfromoptionalcourses.
PgCert HTA:requiresatotalof60creditstobecompletedoverthecourseofthedegree.60creditsfrom3corecourses.
Core courses (20 credits each) • HTA:policyandprinciples • StatisticalMethodsforHTAandevidencebased medicine • HealthEconomicsforHTA
Optional courses (credits) • Decisionanalyticmodellingmethodsfor economicevaluation*(20) • OutcomemeasurementandvaluationforHTA(10) • QualitativeresearchmethodsinHTA(10) • HTAinaglobalcontext(20) • SurvivalanalysisforHTA(10) • Foundationsofdecisionanalyticmodellingfor HTA(10) • Evidencesynthesis(20) • Analysisoflinkedhealthdata(20)
*Thiscourseisonlyavailableasaface-to-facecourseinGlasgow.
‘Great online course, that makes you feel like you are actually in a classroom rather than on your own.’
‘I was sceptical about online learning at first, but it has exceeded my expectations by encouraging participation and providing a vast and useful range of course materials, including recorded lectures.’
‘This course provided a good introduction to survival analysis for HTA, allowing for both a theoretical and practical understanding of the topic.’
‘I’ve found the learning experience to be convenient and flexible. It suits me to participate at a time, and for a duration, that fits my professional and personal schedule too.’
‘I appreciate having so many resources at hand, being able to replay lectures as and when needed to aid understanding and retention.’
‘...a lecture room that goes wherever you want.’
15
Discoverandshareknowledgethatcanchangetheworld-throughinnovative engagementHEHTAhasbeenpromotingitsheadlinemakingresearchandengaginginpublicdiscussionsandactivitiesdemonstratingtheimpactofhealtheconomicresearchondailylivesandhealth.
ExplorathonHEHTAwasselectedtohostaresearchstationatGlasgowScienceCentre.TheeventwaspartofEuropeanResearchers’Night,heldsimultaneouslyacrossEuropeonthelastFridayinSeptemberfundedbytheEuropeanCommissionundertheMarieSklodowska-Curieactionsprogramme.
TheHEHTAstationentitled‘TheHealthMinister’sDilemma’,invitedthepublictobecomedecisionmakersinatrade-offtaskinvolvingabudgetandoptionsforfunding.Researchersalsodemonstratedexamplesofhealthmeasurementtoolsanddiscoveredhowthepublicdefinequalityoflifeandhealth,throughcontributionstoadisplayofvalueofhealthdefinitions.
The Health Minister’s Dilemma stand
Festival of Social SciencesPromotingourportfolioofworkonalcoholinterventionsandoutcomes,theHEHTAteamandcollaboratorsfromNHSScotland(MarkRobinsonandMatthisHeydtmann)hostedastandatGlasgow’sfamousBarrasMarketaspartoftheEconomicandSocialResearchCouncil(ESRC)nationwidefundedFestivalofSocialSciences.Membersofthepublicwereinvitedtospendahypotheticalpotofmoneyonthreeoutoffourinterventionstoreducealcoholconsumptionorchangedrinkingbehaviour.
Thepublicwereaskedtochoosebetweenfundingthefollowinginterventions;minimumunitpricingforalcohol,counsellingtochangedrinkinghabits,bedsinintensivecareforpatientswithliverfailureorsettingthealcohollimitfordrivers.Afterlotsofdeliberationanddiscussion,thefinalresultsindicatethatthepublicvotecomesdownheavilyinfavouroffundingcounsellingtochangedrinkinghabits.
Alcohol interventions- the public decides
Public Health Research Workshop – exploring physical activity for health and funEmmaMcIntoshandManuelaDeiddaparticipatedinthePublicHealthResearchWorkshop,‘Exploringphysicalactivityforhealthandfun’,attheNationalFootballStadiumofScotlandHampdenPark,UK.Theevent,runbytheEUDirectorate-GeneralResearchandInnovation,invitedfiveongoingEuropeanUnionFP7andHorizon2020researchprojectsonhealthenhancingphysicalactivitytosharetheirexperienceswithotherstakeholders,todiscusshowtoenhancephysicalactivity,sharebestpracticesandtodrawsomeconclusionsandrecommendationsforpolicymakers.
16
Highlights of 2016SPRING
WelaunchedourfirstonlineCPDcourse,HealthEconomicsforHTAinApril.SixteenpeopleattendedfromSpain,Indonesia,andtheUK.
AttheBMJAwards,KathleenBoydandEmmaMcIntosh’spaper‘BronchiolitisofInfancyDischargeStudy(BIDS):amulticentre,parallel-group,double-blind,randomisedcontrolled,equivalencetrialwitheconomicevaluation’wasawardedUKClinicalResearchPaperoftheYear.
WewelcomedNeilHawkinsasournewProfessorofHTA.NeilwillleadonournewthemeofEconomicsofPrecisionMedicine.
Some HEHTA team members completetheEdinburgh marathon.
SUMMER
Morecelebrationsas Emma McIntosh was promoted to Professor of HealthEconomics.
JimLewseyandJennieClarkattendedtheSocietyforMedicalDecisionMaking(SMDM)16thBiennialEuropeanConferenceinLondontopresentworkonanaturalexperimentevaluatingtheAlcoholAct.
Robert Heggie (left),completedtheMontBlancmarathon.
Emma McIntosh completedtheIsleofSkyehalfmarathon – what a sporty team!
TheNIHRComplexReviewsSupportUnit(CRSU)turnedoneyearold.TheNIHRCRSUprovidestimelyandappropriatesupportforthedeliveryofcomplexreviewsthatarefundedand/orsupportedbyNIHR.
AbigcongratulationstoCamillaBabawhosuccessfullydefendedherPhDthesisatherviva.
AUTUMN
WewelcomedvisitingresearcherDrCarlosWong,Research Assistant Professor of the Department of FamilyMedicineandPrimaryCareattheUniversityofHongKong.
HEHTAparticipatedintheExplorathoneventatGlasgowScienceCentre(seepage16formoreinformation).
Wewelcomedover80participants to our Decision AnalyticModellingCourse,whichincludedadinneratthestunningOranMor.
18
BuildinglinkswithSouthAmerica,HEHTAwelcomedvisitorsfromBraziltodiscussdifferencesinHTAbetweenthetwocountries.TheBrazilianPublicHealthSystemhas been undergoing major change in thelastfewyearssince the creation oftheNationalCommittee forHealthTechnologyIncorporation (CONITEC).
AspartofourregularGlasgowhealthEconomicsSeminarSeries(GhESS),ProfessorJohnCairnsfromLSHTM presented us with an interesting seminar on ‘A novelmethodforcollectinghealthstateinformationfromchildren’,describingthedevelopmentofanewtoolforcollectingdataonself-reportedhealthfromchildren.
ProfessorPhilipClarke,headfortheHealthEconomicsUnitattheCentreforHealthPolicyatUniversityofMelbourne,Australia,presentedanexcellentGhESS seminaron‘EconomicEvaluation:ABriefHistory’.Itprovidedabroadoverviewofthedevelopmentofeconomicmethodsforevaluatingpublichealthandmedicalinterventionspriortothe1970s.
The team had great fun at the HEHTA Away Day 2016tryingtoescape from The RiddleRoomsandEscape Rooms!
Jim Lewsey reprepresented HEHTA at ISPOR 7th Asia PacificConferenceinSingapore.Aswellaspresentingapaperon‘Developmentofanalcoholpolicymodelthatpredictslifeyears,QALYsandhealthcarecostsaccountingforalcoholusedisorderidentificationtest’,JimwelcomedmanyvisitorstoourstandwhowereinterestedinourMSconlineCPDcourses.
ProfessorJamesRobinsonfromBerkeleyCentreforHealthTechnology,UniversityofCaliforniaprovokedsome great discussion during his seminar about differencesbetweenUSandUKhealthsystems.
WINTER
ProfessorNickHanleyfromtheDepartmentofGeographyandSustainableDevelopment,UniversityofStAndrewsgaveafascinatinglunchtimeseminaratHEHTAonchoicemodelling.
HEHTA participated in theFestivalofSocialSciencesatGlasgow’sBarras.
HEHTA team membersclimbedThe Whangie with CarlosWongasafinalgoodbye.
JanetBouttellwas awarded the firstdistinctionon our MSc HTA programme.
CiaranKohli-LynchwasawardedtheLeeBLustedstudent prize for outstanding presentation of research atSMDMforhisposteron‘SignallingDemand:PCSK9InhibitorsforStatinIntolerantIndividuals’.
HEHTA staff were wellrepresentedat the Institute ofHealthandWellbeing’sChristmas dinner andceilidh!
19
HEHTA’sworkiscentredaroundeightcoreandinterconnectedresearchthemes.
Analysis of Linked Health Data (ALDA)ThisprogrammeencompassesallresearchworkinHEHTAthatisassociatedwithstatistical,epidemiologicalandeconomicanalysisoflinkedhealthdatasets.Ourteamhasawealthofexpertiseandexperienceinthisfield–forexampledatamanipulationandidentifyingcohortswithinlinkeddatasets;regressionmodellingofpaneldatasets;outcomemeasurement,costinganddevelopingdecisionanalyticmodelsusinglinkeddatasets.
Decision Analytic Modelling and Simulation for Evaluation in Health (DAMSEL)This programme encompasses research associated with conductinganevaluationusingmodellingorsimulationmethods.Modellingcanbeusedasthewholeframeworkforanevaluation,oraspartofaclinicaltrial-basedevaluationtoextrapolateintermediatetrialendpointstofinalhealtheconomicoutcomes.DAMSELcutsacrossandinteractswithmanyoftheotherthemesofHEHTA.
Economics of Population Health (EPH)Thisprogrammeisconcernedwiththedevelopmentofmethodsandrelatedempiricalworkassociatedwiththeeconomicevaluationofpopulationhealthinterventions,includingthosethatmaybedeliveredoutsideconventionalhealthservices.Thethemeisparticularlyinterestedintheevaluationof‘up-stream’influences,suchasearlylifeexperiences,thesocialandeconomicconditionsinwhichpeopleliveandenvironmentalexposuresaffectwellbeing.
Incorporating Perspectives and Experiences (IPE) ThisprogrammeaimstopromoteanddeveloptheapplicationofqualitativemethodologiestoHTA.QualitativeresearchisusefulforinvestigatingstakeholderbehavioursandcontextualaspectsofevaluationsandHTA.Researchinthisprogrammefocusesonthedevelopmentandapplicationofqualitativemethodologiestoconceptualmodelling,trialrecruitmentanddesign,developingmeasures,evidencesynthesis,andprocessevaluation.ThethemeoffersatoolkittosupportworkacrossHEHTA’sotherthemes.
Evidence Synthesis (ES) Thisprogrammeencompassesallresearchworkassociatedwithcombiningmultiplesourcesofevidenceforclinicalandeconomicevaluations.AlongsidetheNIHRComplexReviewsSupportUnit(CRSU),thisprogrammewillexplorechallengesincombiningcomplexdatatypesandstructure,throughmethodologicalandappliedresearch.
Economic Evaluation alongside Clinical Trials (EEACT)Thisprogrammeencompassesallresearchworkassociatedwithconductinganeconomicappraisalaspartofaclinicaltrial.Althoughmodellingmethodsmaystillberequiredtoprovideacomprehensiveappraisal,thecharacterisingfeatureistheinclusionofaneconomiccomponenttothetrialandtheavailabilityofexperimentaldataonbothcostsandeffectsoftreatment.
Global HTA (GHTA)ThisprogrammecritiquesHTAindifferentcontexts,exploringvariationbetweenhigh-incomecountriesaswellaslookingin-depthastohowandwhydecisionmakinginhealthcaremaydifferamongstlow-andmiddle-incomecountries(LMICs).ThethemedrawsuponHEHTA’sresearchfromaglobalperspective,workingwithmajorstakeholdersandaspartoftheInternationalDecisionSupportInitiative.
Economics of Precision Medicine (EPM)ThisisHEHTA’snewestprogrammeanddirectlyalignswiththeCollegeofMedical,VeterinaryandLifeSciences(MVLS)roleasoneofthesixregionalcentresofexcellencecreatedbythePrecisionMedicineCatapult.The EPM programme focuses on understanding of the ‘strata’ofresponsesandthegeneticsofthediseases,and effective and cost-effective forms of treatment for differentpatientgroups,methodologicallyunpinnedbysubgroupanalyses.HEHTAishostinganMRCfundedresearchprojectinvestigatingtheuseoffullybayesianmethodstoincreasethereliabilityofsubgroupselection.Inaddition,weareinvestigatingtheimplicationsofprecisionmedicineforstudydesignandtechnologypricing.
Research Themes
21
Projectsawardedin2016
Projects Duration Total Project
Value (£)
Funder Research Theme
Extension of Follow-Up for High Risk Stage II Patients (additional 3 years) and Stage III Patients (up to year 3 follow-up) in the SCOT study.
2016-2018 294,839 NIHR DAMSEL
A woman-centred, tailored SMS-delivered multi-component intervention for weight loss and maintenance of weight loss in the postpartum period: intervention adaptation and pilot RCT
2016-2018 40,500 NIHR EPH
Evaluation of legislation to reduce the drink drive limit in Scotland: a natural experiment
2016-2018 75,000 NIHR ALDA, EPH
Evaluating graduated progress towards indoor smoke free prison facilities in Scotland
2016-2019 437,175 NIHR EEACT
Associations of blood biomarkers with cardiovascular disease and related cardiometabolic outcomes and risk prediction in the clinical setting: UK biobank
2016-2019 75,000 CHSS ALDA
Support to develop and deploy UAV technology for health commodity delivery
2016-2017 141,361 Bill and Melinda Gates Foundation
GHTA
International Decision Support Initiative (iDSI): Supporting Priority-Setting for Universal Health Coverage Phase II
2016-2018 193,175 Bill and Melinda Gates Foundation
GHTA, IPE
Improved metrics to assess impacts of coastal aquaculture farming on community well-being and nutritional status across farmed sea-food value chains in saline floodplains of Bangladesh
2016-2018 247,368 IMMANA GHTA
22
Projects Duration Total Project
Value (£)
Funder Research Theme
Glasgow molecular pathology Node (GMP) 2015-2018 3,481,464 MRC DAMSEL, EPM
Early signs monitoring to prevent relapse and promote wellbeing , engagement and recovery in schizophrenia
2015-2018 406,505 NIHR EEACT
Cardiac biomarkers and the prediction of CVD in Scotland
2015-2018 362,412 CSO DAMSEL
AIM (Ankle Injury Management) The AIM Trial is a pragmatic, multi-centre, individually randomised controlled equivalence study with parallel prospective economic evaluation comparing Close Contact Casting technique (CCC) to Open Reduction and Internal Fixation (ORIF)
2009-2017 70,000 NIHR EEACT
Barrett’s Oesophagus Surveillance versus endoscopy at need Study (BOSS): protocol and analysis plan for a multicentre randomized controlled trial
2009-2022 103,382 NIHR EEACT
A prospective randomised trial of myomectomy versus uterine artery embolisation (UAE) for women withuterine fibroids who wish to retain or improve their fertility (FEMME)
2011-2018 359,804 NIHR EEACT
Surgical Obesity Treatment Study (SCOTS) SurgiCal Obesity Treatment Study. A longitudinal cohort study of bariatric surgery across Scotland following all patients undergoing bariatric surgery in Scotland for a mean of 10 years. Outcomes will include mortality, diabetes incidence, diabetes complications, weight change, surgical complications, quality of life and fractures
2012-2026 2,036,689 NIHR EEACT
Woods in and around towns (WIAT) tackles the barriers people face to visiting and benefitting from woodlands regularly. The programme focuses on the location, accessibility and management of urban woodlands, to encourage more use from local people.
2012-2017 162,085 NIHR EPH
Social and Emotional Education Development 2012-2017 805,527 NIHR EPH
Ongoing projects
23
Projects Duration Total Project
Value (£)
Funder Research Theme
Three-Arm Randomised Control Trial for Mothers Indentified as Vulnerable in Pregnancy and their Babies who are at high risk of maltreatment
2013-2018 1,066,243 NIHR EEACT
BEAT-IT: A randomised controlled trial comparing a behavioural activation treatment for depression in adults with learning disabilities with an attention control.
2012-2017 783,006 NIHR EEACT
Cost-effectiveness of Theophylin for the treatment of COPD / (TWICS)
2012-2017 783,006 NIHR EEACT
E-Health Informatics Research Centres (E-HIRCs) - Farr Studentship
2012-2017 1,073,113 MRC ES, DAMSEL
A Randomised Controlled Trial of the Effectiveness of PDSAFE to prevent Falls among People with Parkinson’s Disease.
2013-2017 79,215 Parkinsons UK EEACT
Cancer and Venous Access (CAVA) randomised controlled trial of long-term venous access devices for the delivery of chemotherapy: ports versus tunnelled central lines versus percutaneous inserted central catheters
2013-2018 1,031,483 NIHR ES, IPE, DAMSEL
ADScAN:A Randomised Phase II study of Accelerated, Dose escalated, Sequential Chemo-radiotherapy in Non Small Cell Lung Cancer
2015-2021 28,431 CTAAC DAMSEL
CULPRIT SHOCK - Multivessel versus culprit lesion only percutaneous revascularization in patients with acute myocardial infarction complicated by cardiogenic shock’.
2013-2017 301,170 European Commission
EEACT
Effectiveness of a physical activity loyalty card for sustainable behaviour change
2014-2018 49,427 NIHR EPH
Early CDT Lung Test study 2012-2019 331,194 Oncimune Ltd EEACT
Oral Versus Intravenous Antibiotics (OVIVA) 2012-2017 66,837 NIHR EEACT
Ongoing projects continued
24
Ongoing projects continued
Projects Duration Total Project
Value (£)
Funder Research Theme
A randomised Phase 2 Trial of standard versus dose escalated radiotherapy in the treatment of pain in malignant pleural mesothelioma
2014-2017 130,312 Beatson Cancer Charity
EEACT
Helpmedoit!’ a web, app and text based intervention to facilitate social support to achieve and maintain health related change in physical activity and dietary behaviour
2015-2017 526,866 NIHR EPH, EEACT
Evaluation of the Healthy Start Voucher Scheme in UK: a natural experiment using the Growing Up in Scotland record linkage study and the Infant Feeding Survey.
2015-2017 556,452 NIHR EPH
Quantitative Fibronectin to help Decision making in women with symptoms of Preterm Labour – The QUIDS study
2015-2018 59,726 NIHR DAMSEL
A pilot evaluation of an intelligent liver diagnostic pathway
2015-2017 66,926 CSO DAMSEL
Reducing sedentary behaviour among older adults – The SITLESS Project
2015-2019 228,818 European Commission
EEACT, EPH
Technology enabled behavioural change as a pathway towards better self-management of CVD (PATHway)
2015-2018 209,927 European Commission
DAMSEL, EEACT
CRSU Complex reviews support unit 2015-2020 2,000,000 NIHR ES
The Football Fans in Training follow up RCT 2015-2017 341,619 NIHR EEACT, DAMSEL, EPH
Evaluation of the New Orleans Intervention model – BEST
2016-2020 2,751,519 NIHR EEACT, EPH
25
Projects Duration Total Project
Value (£)
Funder Research Theme
Symptoms, quality of life and place of care study 2015-201 91,981 BHF DAMSEL
Web based physiotherapy for people with multiple sclerosis
2014-2016 670,689 Multiple Sclerosis Society
DAMSEL, EEACT
Pragmatic Ischaemic Thrombectomy Evaluation (PISTE) trial: A randomised controlled trial of mechanicalthrombectomy in acute ischaemic stroke
2015-2016 926,979 NIHR DAMSEL, ES
Evaluation of the links worker programme in deep end general practices in Glasgow
2014-2016 300,000 NHS Health Scotland
EPH
International Decision Support Initiative (iDSI): Supporting Priority-Setting for Universal Health Coverage
2014-2016 56,455 NICE International GHTA
The effect of geography and socioeconomic status on health care costs at the end of life: implications for resource allocation and expenditure projections in Scotland
2014-2016 167,340 CSO ALDA
Reducing alcohol consumption in Obese Men - Development and Feasibility Testing of a Complex Community-based Intervention.
2014-2016 4,690 NIHR EEACT
A very early rehabilitation trial after stroke. A phase 3 multi-care randomised controlled trial (AVERT)
2013-2016 451,885 NIHR ES , EEACT
Selling Stroke Services in an International context 2014-2016 47,758 CHSS ES
Projectscompletedin2016
26
TheNIHRComplexReviewsSupportUnit(CRSU),acollaborationbetweentheUniversityofGlasgow,theUniversityofLeicesterandLondonSchoolofHygieneandTropicalMedicine,isledbyProfessorOliviaWu.CRSUisfundedbyNIHR(Projectnumber14/178/29)tosupportandencouragesuccessfuldeliveryofcomplexreviewsofimportancetotheUKNHS,whilstbuildingcapacityandcapabilitywithintheresearchcommunitythroughthesupportgiven.
During2016,theUnithasundertakenaprogrammeofevents to reach out to the NIHR research community andinparticulartheCochraneOrganisation.TwosuccessfulworkshopswereheldatTheCochraneUKandIrelandSymposium2016inBirminghaminMarch;‘MethodologicalChallengesinComplexReviews’and‘TheNIHRSystematicReviewsProgramme:OpportunitiesforGreaterImpact’.Afurthertwoworkshopsubmissions were accepted for the Cochrane UK and IrelandSymposium2017.Inaddition,attheinvitationof the Cochrane Dementia and Cognitive Improvement Group(CDCIG),CRSUranaworkshoponaccumulatingevidence,sequentialsynthesisandthechallengeofmultiplicityinSeptember,whichwasverywellreceived.
CRSUwaspleasedtoparticipateintheCochraneColloquium2016,inKoreainOctober,whereDrHilaryThomsonrepresentedthegroupattheposterpresentationsession.
InadditiontosupportingindividualCochraneReviewGroups,includingDementiaandCognitiveImprovementGroup,Gynaecological,Neuro-oncologicalandOrphanCancersGroup,HeartGroupandAirwaysGroup,theUnithasworkedcloselyonsupportingeightfullapplicationstotheNIHRCochraneProgrammeGrantsScheme.
ThefirstofaseriesofSeminarswithCuttingEdgeMethods,‘Aggregatingevidenceaboutthepositiveandnegativeeffectsoftreatmentsusingacomputationalmodelofargument’,washeldattheUniversityofLeicesterinMarch2016.
Overall,CRSUhashadachallengingandfulfillingyear,buildingasuccessfulworkingrelationshipwiththeNIHRresearchcommunityinsupportingtheUKNHStodeliverclinically-andcost-effectiveservicesthatareevidence-based.ForfurtherinformationonCRSUseeourwebsiteatwww.nihrcrsu.org
Moira Aitken, CRSU Project Manager
NIHRComplexReviewSupportUnit(CRSU)
27
CaoimheRyantalksaboutworkingatHEHTA
Tell us a little about your background Mybackgroundisinpsychology.AsanundergraduateIstudiedpsychologyatUniversityCollegeDublin.IearnedmyMScinsocialandculturalpsychologyattheLondonSchoolofEconomics,afterwhichIworkedforanumberofyearsinhealthpsychologyresearchattheUniversityofStirlingandlatertheUniversityofStrathclyde.IeventuallyreturnedtostudyandlastyeargraduatedfromtheUniversityofStAndrewswithaPhDinsocialpsychology.
What attracted you to HEHTA?
Iwasinterestedinsteppingoutofpsychologytoworkinamultidisciplinarycontextandgainexperienceinappliedresearch.IwasparticularlydrawntoHEHTA’s‘Incorporating Patient Perspectives and Experiences’ researchtheme.Withinthistheme,mycurrentworkispartofanRCTthataimstoevaluatetheclinical-andcost-effectivenessofvenousaccessdevices.Myroleistosupportthisevaluationwithaqualitativeinvestigationofpatientandclinicianexperienceswiththesedevices.Iseealotofvalueinapproachestohealthtechnologyassessment that incorporate subjective experiences of healthinterventions.
What aspects of the work you do at HEHTA do you think will help your future career? Workingaspartofalarge-scalemulti-siteRCThasbeenveryinstructive.I’velearnedalotabouthowtrialsaremanagedandcoordinated,abouttheissuestrialsface,abouttherolesoftrialmanagers,clinicalresearchers,stakeholders,andpatients,andaboutwhatittakestorunasuccessfultrial.Inparticular,Ithinkthatunderstandingthewaysinwhichqualitativeresearchcancontributetosuchtrialsaddrealvaluewillbehelpfulinmyfuturecareer.
Do you enjoy Glasgow as a place to live and work? I’velivedinGlasgowformanyyears–eventhroughoutmystudiesatStAndrewsUniversity–andIfeelveryathomehere.Tome,Glasgowfeelsverydowntoearth,open,andprogressive.It’salivelyandinterestingcity,andaneasyplacetolive.Foranyonewhoenjoystheoutdoors,Glasgowisideal.There’saplethoraofgreatparksdottedaroundthecity,thebeautifulCampsieFellsarerightonyourdoorstep,andLochLomondandtheTrossachsareastone’sthrowbeyondthat.
29
MSc HTA programme
HTA: Policy and Principles
Jim Lewsey HannahHesselgreaves OliviaWu NickiBoyer Emma McIntosh ZahidQuayyum KathleenBoyd NicolaMcMeekin EleanorGrieve Yiqiao Xin
Health Economics for HTA
KathleenBoyd ClaudiaGeue Jim Lewsey Emma McIntosh NicolaMcMeekin EleanorGrieve
Outcome Measurement and Valuation for HTA
Emma McIntosh Yiqiao Xin EleanorGrieve
Qualitative Methods in HTA
HannahHesselgreaves
Decision Analytic Modelling Methods
Andrew Briggs OliviaWu KathleenBoyd NeilHawkins
Throughout2016HEHTAstaffalsocontributedtoteachingonnumerousotherprogrammesincludingtheMastersinPublicHealth,MBChB,MScHumanNutrition,MScGlobalMentalHealth,MScCancerStudies,MScGlobalHealthandManagement(UniversityofAberdeen).
Claudia Geue and Mohsen Rezaiehemami supervised MPH student Naomi Ferguson
Projecttitle:‘Cost-effectivenessoftreatingHepatitisCinSeychelles’
Olivia Wu and Yiqiao Xin supervised MPH student Jenny Harbour
Projecttitle:‘Comparativeeffectivenessofinterventionsforalcoholicliverdisease:asystematicreviewandnetworkmeta-analysis’
Kathleen Boyd and Nicola McMeekin supervised MSc HTA student Evidence Nyamadzawo
Projecttitle:‘Mindfulnessbasedcognitivebehaviouraltherapydecisionmodel’
Janet Bouttell and Neil Hawkins supervised MSc HTA student Dmitry Ponomarev
Projecttitle:‘Impactofpotentialbiomarkerinovariancancer’
Teaching Supervision
31
Online distance learning
In2016,HEHTAlaunchedsomeofitsMScmodulesasonlineCPDcoursesforthefirsttime:
• HealthEconomicsforHTA • HTA:policyandprinciples • OutcomemeasurementandvaluationforHTA • QualitativeresearchmethodsinHTA
Healthpractitionersandresearchersfromallovertheworldwereabletobenefitfromourfirst-classteachingmaterialandgainexperttraininginavarietyofnewskillsatafractionofthecostofattendingaface-to-facecourse.Participantsconnectwithfellowstudentsandtutorsthroughourvirtuallearningenvironmentwheretheyhaveaccesstomanydifferentlearningresourcesincludingrecordedlectures,videosandinteractivequizzes.Teachingisresearch-ledandthecourseshavebeendevelopedtoreflectthelatestacademicresearchandup-to-datechallengesinHTAdecision-making.
Themodulescompriselecturesandaccompanyingpracticalexercises.Thecoursesplacegreatemphasisonsupportandinteraction.Eachweektheacademicleadwilldirectandobservetheforumdiscussionandrespondtoparticipantquestionsaboutthecoursecontent.Theonlinecoursehastheaddedbenefitofbeingflexiblearoundparticipants’schedules,makingitanidealwaytoupskill.
Face-to-face
Decision Analytic Modelling Methods for Economic Evaluation
Firstrunin2007thiscoursehasprovedextremelypopular,withnumbersincreasingyear-on-year.Thecoursehastwolevels:atwo-dayfoundationlevelcoursefollowedbyathree-dayadvancedlevelcourse.
Thefoundationscourseisaimedathealtheconomistsandhealthprofessionalswithexperienceofhealtheconomics,whowishtodevelopskillsandknowledgeindecisionanalysisforpurposesofcosteffectivenessanalysis.Theadvancedcourseisaimedatthosewithexpereinceofhealtheconomicswhowishtolearnaboutrecentmethodologicaldevelopmentsincost-effectivenessanalysis.
In2016wehad39participantsonourFoundationscourseand63ontheAdvancedcourse.
‘Best course in health economics modelling out there! Excellent teachers, tutors, material and experience’
‘Very useful course, would recommend it to everyone interested in gaining advanced knowledge in economic modelling.’
‘The most useful health economics course I have attended!’
‘Excellent thorough introduction to HEOR’
‘...gives you a great overview about different modelling techniques’
‘Top notch course on economic modelling’
‘The course was very well organised, with really helpful administration staff. It was led by highly qualified lecturers.’
‘Great online course, that makes you feel like you are actually in a classroom rather than on your own.’
33
Baba C,KearnsA,McIntosh E,TannahillC,Lewsey J. Is empowermentaroutetoimprovingmentalhealthandwellbeinginanurbanregeneration(UR)context?UrbanStudies.2016;54(7):1619-1637.
Baba C.Valuingthehealthandwellbeingaspectsofcommunityempowerment in an urban regeneration context using economic evaluationtechniques.PhDThesis,UniversityofGlasgow.2016.
BalaliM,KamalidehghanBFM,AhmadipourF,AshkezariMD,Hemami MR,ArabzadehH,etal.AssociationofnuclearandmitochondrialgeneswithaudiologicalexaminationsinIranianpatientswithnonaminoglycosideantibiotics-inducedhearingloss.TherapeuticsandClinicalRiskManagement.2016;12:117-28.
BeckerU,Briggs A,MorenoSG,RayJA,NgoP,SamantaK.Cost-EffectivenessModelforChemoimmunotherapyOptionsinPatientswithPreviouslyUntreatedChronicLymphocyticLeukemiaUnsuitableforFull-DoseFludarabine-BasedTherapy.ValueHealth.2016;19(4):374-82.
Bouttell J, Lewsey J, Geue C,AntonyG,Briggs AH,McCartneyG,etal.TheScottishAlcoholicLiverdiseaseEvaluation:APopulation-LevelMatchedCohortStudyofHospital-BasedCosts,1991-2011.PLoSOne.2016;11(10):e0162980.
Boyd KA, Briggs AH,BauldL,SinclairL,TappinD.Arefinancialincentivescost-effectivetosupportsmokingcessationduringpregnancy?Addiction.2016;111(2):360-70.
Boyd KA,TappinDM,BauldL.Cost-effectivenessoffinancialincentivesforsmokingcessationinpregnancy.Addiction.2016;111(6):115-7.
Boyer NR,MillerS,ConnollyP,McIntosh E.PavingthewayfortheuseoftheSDQineconomicevaluationsofschool-basedpopulationhealthinterventions:anempiricalanalysisoftheexternalvalidityofSDQmappingalgorithmstotheCHU9Dinaneducationalsetting.QualityofLifeResearch.2016;25(4):913-23.
Briggs AH.AViewfromtheBridge:HealthEconomicEvaluation—AValue-BasedFramework?HealthEconomics.2016;25(12):1499-502.
Briggs AH,NugentR.Economicevaluationsinlow-andmiddle-incomecountries:Methodologicalissuesandchallengesforpriority-setting.HealthEconomics.2016;25:6-8.
BrockPM,FornaceKM,Parmiter M,CoxJ,DrakeleyCJ,FergusonHM,etal.Plasmodiumknowlesitransmission:integratingquantitativeapproachesfromepidemiologyandecologytounderstandmalariaasazoonosis.Parasitology.2016;143(4):389-400.
EganM,KearnsA,KatikireddiSV,CurlA,Lawson K,TannahillC.Proportionateuniversalisminpractice?Aquasi-experimentalstudy(GoWell)ofaUKneighbourhoodrenewalprogramme’simpactonhealthinequalities.SocialScience&Medicine.2016;152:41-9.
FisherA,AndreassonA,ChrysosA,LallyJ,MamasoulaC,ExleyC,etal.AnobservationalstudyofDonorExVivoLungPerfusioninUKlungtransplantation:DEVELOP-UK.HealthTechnolAssess.2016;20(85):1-276.
Geue C, Lewsey JD,MacKayDF,AntonyG,FischbacherCM,MuirieJ,etal.ScottishKeepWellhealthcheckprogramme:aninterruptedtimeseriesanalysis.JEpidemiolCommunityHealth.2016;70(9):924-29.
Geue C, Wu O,LeylandA,Lewsey J,QuinnTJ.Geographicvariationofinpatientcarecostsattheendoflife.AgeandAgeing.2016;45(3):376-81.
GurusamyKS,PallariE,Hawkins N,PereiraSP,DavidsonBR.Managementstrategiesforpancreaticpseudocysts.CochraneDatabaseSystRev.2016;4:CD011392.
HunterRF,BrennanSF,TangJ,SmithOJ,MurrayJ,TullyMA,etal.Effectivenessandcost-effectivenessofaphysicalactivityloyaltyschemeforbehaviourchangemaintenance:aclusterrandomisedcontrolledtrial.BMCPublicHealth.2016;16(1):1-12.
KeshavarzK,KebriaeezadehA,AlavianSM,AkbariSariA,Rezaei Hemami M,LotfiF,etal.ACost-UtilityandCost-EffectivenessAnalysisofDifferentOralAntiviralMedicationsinPatientsWithHBeAg-NegativeChronicHepatitisBinIran:AnEconomicMicrosimulationDecisionModel.HepatitisMonthly.2016;16(9):e37435.
LawsonKD,Lewsey JD,FordI,FoxK,RitchieLD,Tunstall-PedoeH,etal.Acardiovasculardiseasepolicymodel:part2-preparingforeconomicevaluationandtoassesshealthinequalities.OpenHeart.2016;3(1):e000140.
LeeMM,PetrieMC,RocchiccioliP,SimpsonJ,JacksonC,BrownA,etal.Non-invasiveversusinvasivemanagementinpatientswithpriorcoronaryarterybypasssurgerywithanon-STsegmentelevationacutecoronarysyndrome:studydesignofthepilotrandomisedcontrolledtrialandregistry(CABG-ACS).OpenHeart.2016;3(1):e000371.
LewisSC,BhattacharyaS, Wu O,VincentK,JackSA,CritchleyHO,etal.GabapentinfortheManagementofChronicPelvicPaininWomen(GaPP1):APilotRandomisedControlledTrial.PLoSOne.2016;11(4):e0153037.
LukerJA,CraigLE,BennettL,ElleryF,LanghorneP,Wu O,etal.Implementingacomplexrehabilitationinterventioninastroketrial:aqualitativeprocessevaluationofAVERT.BMCMedicalResearchMethodology.2016;16(1):52.
McAuleyA,Bouttell J,BarnsdaleL,MackayD,Lewsey J,HunterC,etal.Evaluatingtheimpactofanationalnaloxoneprogrammeonambulanceattendanceatoverdoseincidents:acontrolledtimeseriesanalysis.Addiction.2016;112(2):301-8.
McCartneyG,Bouttell J,CraigN,CraigP,GrahamL,LakhaF,etal.Explainingtrendsinalcohol-relatedharmsinScotland,1991-2011(I):theroleofincomes,effectsofsocio-economicandpoliticaladversityanddemographicchange.PublicHealth.2016;132:13-23.
McCartneyG,Bouttell J,CraigN,CraigP,GrahamL,LakhaF,etal.Explainingtrendsinalcohol-relatedharmsinScotland1991-2011(II):policy,socialnorms,thealcoholmarket,clinicalchangesandasynthesis.PublicHealth.2016;132:24-32.
McIntosh E,GrayA,DanielsJ,GillS,IvesN,JenkinsonC,etal.Cost-utilityanalysisofdeepbrainstimulationsurgeryplusbestmedicaltherapyversusbestmedicaltherapyinpatientswithParkinson’s:EconomicevaluationalongsidethePDSURGtrial.MovementDisorders:2016;31(8):1173-78.
MealingS,WoodsB,Hawkins N,CowieMR,PlummerCJ,AbrahamWT,etal.Cost-effectivenessofimplantablecardiacdevicesinpatientswithsystolicheartfailure.Heart.2016;102(21):1742-49.
35
MercerSW,FitzpatrickB,GuthrieB,FenwickE,Grieve E,LawsonK,etal.TheCAREPlusstudy–awhole-systeminterventiontoimprovequalityoflifeofprimarycarepatientswithmultimorbidityinareasofhighsocioeconomicdeprivation:exploratoryclusterrandomisedcontrolledtrialandcost-utilityanalysis.BMCMedicine.2016;14(1):1-10.
MinnisH,Boyd KA,FitzpatrickB,FordeM,GillbergC,HendersonM,McMahonL,McIntosh,Eetal.‘Protocol15PRT/6090:TheBestServicesTrial(BeST?):Effectivenessandcost-effectivenessoftheNewOrleansInterventionModelforInfantMentalHealth’.TheLancet. http://www.thelancet.com/protocol-reviews/15PRT-6090
MoiseN,HuangC,RodgersA,Kohli-Lynch CN,TzongKY,CoxsonPG,etal.ComparativeCost-EffectivenessofConservativeorIntensiveBloodPressureTreatmentGuidelinesinAdultsAged35-74Years:TheCardiovascularDiseasePolicyModel.Hypertension.2016;68(1):88-96.
NahvijouA,DaroudiR,TahmasebiM,AmouzegarHashemiF,Rezaei Hemami M,AkbariSariA,etal.Cost-EffectivenessofDifferentCervicalScreeningStrategiesinIslamicRepublicofIran:AMiddle-IncomeCountrywithaLowIncidenceRateofCervicalCancer.PLoSOne.2016;11(6):e0156705.
ParkinsonJ,MintonJ,Lewsey J, Bouttell J,McCartneyG.RecentcohorteffectsinsuicideinScotland:alegacyofthe1980s?JournalofEpidemiologyandCommunityHealth.2016;71(2):194-200.
SaffariN,Salmanzadeh-AhrabiS,Abdi-AliA,Rezaei-Hemami M.AcomparisonofantibioticdisksfromdifferentsourcesonQuicolorandMueller-Hintonagarmediainevaluationofantibacterialsusceptibilitytesting.IranianJournalofMicrobiology.2016;8(5):307-11.
SheppardL,DeweyH,BernhardtJ,CollierJM,ElleryF,ChurilovL,etal.EconomicEvaluationPlan(EEP)forAVeryEarlyRehabilitationTrial(AVERT):Aninternationaltrialtocomparethecostsandcost-effectivenessofcommencingoutofbedstandingandwalkingtraining(veryearlymobilization)within24hofstrokeonsetwithusualstrokeunitcare.InternationalJournalofStroke.2016;11(4):492-4.
StadlerN,ShangA,BoschF,Briggs AH,GoedeV,BerthierA,etal.ASystematicReviewandNetworkMeta-AnalysistoEvaluatetheComparativeEfficacyofInterventionsforUnfitPatientswithChronicLymphocyticLeukemia.AdvancesinTherapy.2016;33(10):1814-30.
ThompsonJC,QuigleyJM,HalfpennyNJ,ScottDA,Hawkins N.ImportanceandmethodsofsearchingforE-publicationsaheadofprintinsystematicreviews.Evidence-BasedMedicine.2016;21(2):55-9.
TiffinPA,MwandighaLM,PatonLW,Hesselgreaves H,McLachlanJC,FinnGM,etal.PredictivevalidityoftheUKCATformedicalschoolundergraduateperformance:anationalprospectivecohortstudy.BMCMed.2016;14(1):140.
TremblayG,LivingsC,CroweL,KapetanakisV,Briggs AH.Determinationofthemostappropriatemethodforextrapolatingoverallsurvivaldatafromaplacebo-controlledclinicaltrialoflenvatinibforprogressive,radioiodine-refractorydifferentiatedthyroidcancer.ClinicoEconomicsandOutcomesResearch.2016;8:323-33.
WildmanJ,McMeekin P, Grieve E, Briggs AH.Economicevaluationofintegratednewtechnologiesforhealthandsocialcare:Suggestionsforpolicymakers,usersandevaluators.SocialScience&Medicine.2016;169:141-8.
WillettK,KeeneDJ,MistryD,NamJ,TuttonE,HandleyR,etal.CloseContactCastingvsSurgeryforInitialTreatmentofUnstableAnkleFracturesinOlderAdults:ARandomizedClinicalTrial.JAMA.2016;316(14):1455-63.
Williams C, Lewsey J, Briggs, AH.Mackay,D.Estimationofsurvivalprobabilitiesforuseincost-effectivenessanalysis:acomparisonofamulti-statemodellingsurvivalanalysisapproachwithpartitionedsurvivalandMarkovdecision-analyticmodelling.MedicalDecisionMaking.2016;37(4):427-39.
Williams C, Lewsey, J, Briggs, AH.Cost-effectivenessanalysisinRusingamulti-statemodellingsurvivalanalysisframework:Atutorial.MedicalDecisionMaking.2016;37(4):340-52.
Wu O, Boyd K,PaulJ,McCartneyE,Ritchie M,MellonD,etal.Hickmancatheterandimplantableportdevicesforthedeliveryofchemotherapy:aphaseIIrandomisedcontrolledtrialandeconomicevaluation.BrJCancer.2016;114(9):979-85.
Xin Y,MansonJ,Govan L,HarbourR,BennisonJ,WatsonE,etal.PharmacologicalregimensforeradicationofHelicobacterpylori:anoverviewofsystematicreviewsandnetworkmeta-analysis.BMCGastroenterology.2016;16(1):80.
Xin Y, McIntosh E.Assessmentoftheconstructvalidityandresponsivenessofpreference-basedqualityoflifemeasuresinpeoplewithParkinson’s:asystematicreview.QualityofLifeResearch.2016;26(1):1-23.
36
Presentations
KathleenBoyd,‘ADSCaN:ARandomisedPhaseIIstudyofAccelerated,Doseescalated,SequentialChemo-radiotherapyinNon-SmallCellLungCancer(NSCLC)’,14thAnnualBritishThoracicOncologyGroup(BTOG)Conference2016,Dublin,Ireland,28January2016
EleanorGrieve,‘EvaluationtheimpactofHTAand‘betterdecision-making’onhealthoutcomes’,CentreforHealthEconomicsseminars2016,York,UK,3March2016
AndrewBriggs,‘Theeconomicsoftestinganddiagnosisincancer:quantifyingthevalueofinformation’,HORGSeminarSeries,MemorialSloanKetteringCancerCentre,NewYork,USA,4March2016
CiaranKohli-Lynch,‘Long-termbenefitsofbloodpressureloweringinyoungadulthood:acomputersimulationstudy’,AmericanHeartAssociationEpidemiology/Lifestyle2016ScientificSessions,Phoenix,USA,7March2017
HannahHesselgreaves,‘Factorsaffectingrecruitmenttohigherspecialtytraining:aquestionnairestudy’,RoyalCollegeofPhysiciansMedicine(RCP)annualconference,Harrogate,UK,15-16March2016
CamillaBaba,‘ValuingCommunityEmpowermentinanUrbanRegenerationContextasanalternativepathwaytohealthgains:aDiscreteChoiceExperiment’,13thInternationalConferenceonUrbanHealth,SanFrancisco,USA,3April2016
HannahHesselgreaves,CAVATrialqualitativeresearch,PortCourse,UniversityofGlasgow,7April2016
CamillaBaba,‘ValuingCommunityEmpowermentinanUrbanRegenerationContextasanalternativepathwaytohealthgains:aDiscreteChoiceExperiment’,CentreforHealthEconomics,York,UK,12May2016
OliviaWuandNeilHawkins,‘AFrameworkForAssessingEvidenceForHTAInContext’–paneldiscussion,HTAi2016,Tokyo,Japan,13May2016
OliviaWu,‘AQualityStandards:ImplementingValue-BasedHTADecisionsForUniversalHealthCoverage’–paneldiscussion,HTAi2016,Tokyo,Japan,14May2016
EmmaMcIntosh,‘TheEconomicsofPrevention’,PublicHealthAnnualResearchandPracticeConference2016,Belfast,UK,8June2016
MohsenRezaei,‘CostEffectivenessOfDifferentCervicalScreeningStrategiesInI.R.Iran:AMiddle,IncomeCountryWithALowIncidenceRateOfCervicalCancer’,IARCConference-GlobalCancer:Occurrence,Causes,andAvenuestoPrevention,Lyon,France,8June2016
37
JimLewsey,‘TheimpactoftheAlcoholActonalcohol-relatedhealthharmsinScotland’,SocietyofMedicalDecisionMaking(SMDM)Europe2016,London,12June2016
YiqiaoXin,JimLewseyandEmmaMcIntosh,‘BroadeningtheevaluativescopeofqualityoflifeinParkinson’s:TestingtheconstructvalidityoftheICECAP-Oinstrument’,20thInternationalcongressofParkinson’sdiseaseandmovementdisorders,Berlin,Germany,20June2016
NickiBoyer,‘Populationhealtheconomicevaluationoftheschool-basedRootsofEmpathyprogrammeinNorthernIreland’,HESG2016,GranCanaria,Spain,21June2016
YiqiaoXin,‘TestingtheconstructvalidityoftheICECAP-OinstrumentinParkinson’sandexploringitsrelationshipwiththeEQ-5D-3LandtheParkinson’sspecificqualityoflifequestionnairethePDQ-39’,HESG2016,GranCanaria,23June2016
JoseRobles-Zurita,‘Randomnessbeliefsanddecisionsonriskymedicaltreatments’,IAREP/SABE2016Conference“BehaviouralInsightsinResearchandPolicyMaking”,Wageningen,Netherlands,7July2016
CamillaBaba,‘ValuingCommunityEmpowermentinanUrbanRegenerationContextasanalternativepathwaytohealthgains:aDiscreteChoiceExperiment’PublicHealthPhDsymposium,JohnMooreUniversity,Liverpool,UK,7July2016
ClaudiaGeue,‘DeterminantsofhealthcareexpenditureattheendoflifeforcancerpatientsinScotland’,EuHEA2016,Hamburg,Germany,14July2016
ClaudiaGeue,‘TheScottishKeepWellHealthCheckprogramme:aninterruptedtimeseriesanalysis’,EuHEA,Hamburg,Germany,15July2016
NickiBoyer,‘Populationhealtheconomicevaluationoftheschool-basedRootsofEmpathyProgrammeinNorthernIreland’,EuHEA2016,Hamburg,Germany,15July2016
GiorgioCiminata,‘TheinpatientandsocialcarecostofatrialfibrillationinScotland’,EuHEA2016,Hamburg,Germany,15July2016
NicolaMcMeekin,‘Canconceptualmodellingmethodologyfromotherdisciplinesinformconceptualmodellingmethodologyineconomicevaluationsofhealthcare?’,EuHEA2016,Hamburg,Germany,15July2016
OliviaWu,‘Thresholdsanddecision-making:howaredecisionsmadeataNICETechnologyAppraisalCommittee?’,CientificaIVFaff,Salvador,Brazil,27July2016
OliviaWu,‘AdoptionofnewtechnologiesforrarediseaseintheUK’,CientificaIVFaff,Salvador,Brazil,28July2016
OliviaWu,‘UsingQualityAdjustedLifeYears(QALYs)inEconomicEvaluation’,CientificaIVFaff,Salvador,Brazil,29July2016
ClaudiaGeue,‘Theimpactofsocialcareexpenditureattheendoflife:anovellinkagestudyinScotland’,InternationalPopulationDataLinkageConference,Swansea,UK,24August2016
GiorgioCiminata,‘TheinpatientandsocialcarecostofatrialfibrillationinScotland’,InternationalPopulationDataLinkageConference,Swansea,UK,24August2016
MohsenRezaei,‘Acost-utilityanalysisofdifferentantiviralmedicineregimensinpatientswithchronichepatitiscvirusgenotype1infection:aneconomicmicro-simulationdecisionmodel’,ISPOR7thAsia-PacificConference,Singapore,4September2016
JimLewsey,‘Developmentofanalcoholpolicymodelthatpredictslifeyears,QALYs,andhealthcarecostsaccountingforalcoholusedisorder’,ISPOR7thAsia-PacificConference,Singapore,5September2016
EleanorGrieve,‘Frompriority-settingdecisionstohealthimpact:newexplorationsofacomplextranslationprocess’,InternationalSocietyonPrioritiesinHealthCareconference,Birmingham,UK,7September2016
ClaudiaGeue,‘WorkplanfortheHealthEconomicsWorkPackage’,ECHorizon2020PATHwayConsortiummeeting,Thessaloniki,Greece,20September2016
OliviaWu,‘HowNICEappraisalsupportstherationalaccesstonewandexpensivemedication’,45thESCPSymposiumonClinicalPharmacy,Oslo,Norway,3October2016
AndrewBriggs,‘Impactofeconomiccrisesonhealthcarefunding’,MakeBetterSummit,Berlin,Germany,7October2016
CiaranKohli-Lynch,‘Signallingdemand:PCSK9InhibitorsforStatinIntolerantIndividuals’,SMDMNorthAmerica,23October2016
CiaranKohli-Lynch,‘PrioritisingIndividualsforPreventiveStatinTherapy:BeyondTen-YearRisk’,SMDMNorthAmerica,23October2016
MoiraAitken,‘NIHRCRSU–theNationalInstituteforHealthResearchComplexReviewsSupportUnit:supportingsuccessfuldeliveryofcomplexreviews’,CochraneColloquium,GrandHilton,Seoul,Korea,23October2016
JanetBouttell,‘MethodsofEarlyHealthTechnologyAssessmentinPrecisionMedicine’,GMPNodeAnnualSymposium,Glasgow,UK,24October2016
JanetBouttellandJimLewsey‘Age,PeriodandCohort(APC)effectsinsuicideinScotland’,FacultyofPublicHealthConference,Dunblane,Scotland,27October2016
OliviaWuandNeilHawkins,‘Meta-Analysis&SystematicLiteratureReview’,ISPOREurope2016,Vienna,Austria,29October2016
AndrewBriggs,‘CollectingHealth-StateUtilityEstimatesforEconomicModelsinClinicalStudies’,ISPOREurope2016,Vienna,Austria,29October2016
NeilHawkins,‘DevelopmentofConceptualModels’,ISPOREurope2016,Vienna,Austria,29October2016
GiorgioCiminata,‘Theprescribing,inpatient,outpatientandsocialcarecostsassociatedwithatrialfibrillationinScotland’,ISPOREurope2016,Vienna,Austria,29October2016
38
NeilHawkinsandOliviaWu,‘Theevolvingroleofreal-worlddatainevidencesynthesistomeetdemandsforevidence-basedmedicine’,ISPOREurope,Vienna,Austria,30October2016
AndrewBriggs‘UnderstandingSurvivalModellingwithApplicationtoHTA’,ISPOREurope2016,Vienna,Austria,30October2016
AndrewBriggs,‘IntroductiontotheEconomicAnalysisofDiagnostics’,ISPOREurope2016,Vienna,Austria,30October2016
OliviaWu,‘LostinTranslation’,ISPOREurope2016,Vienna,Austria,30October2016
NeilHawkins,‘SynthesisofBinaryOutcomeDataontheLog-OddsandAbsoluteRiskScales–ACaseStudyinChronicHepatitis’,ISPOREurope2016,Vienna,Austria,31October2016
ClaudiaGeue,‘HealthEconomicsinEndofLifeCare’,ICAMs–InstituteofCardiovascularandMedicalSciences,Glasgow,UK3November2016
JoseRobles-Zurita,‘Randomnessbeliefsanddecisionsonriskymedicaltreatments’,MDXExperimental/BehavioralSeminarSeries,DepartmentofEconomicsatMiddlesexUniversityLondon,9November2016
AndrewBriggs,‘HealthTechnologyAssessment’,Biogen,Copenhagen,Denmark,28November2016
GiorgioCiminata,‘Theprescribing,inpatient,outpatientandsocialcarecostsassociatedwithatrialfibrillationinScotland’,UKStrokeForum,Liverpool,28November2016
39
Andrew Briggs Editor,HealthEconomics
AssociateEditor,ValueinHealth
TrialSteeringCommittee:NOSH
TrialSteeringCommittee:DISCHARGE
Eleanor Grieve MemberofESRCGlobalChallengesResearchFundPeerReviewGroup
Emma McIntosh MemberofEditorialBoardforBMCMedicalResearchMethodology
AdvisoryBoardMember,CSONationalBurdenofDisease,InjuriesandriskFactors
AdvisoryBoardMember,ScottishImmunisationProgramme-Epidemiology&Surveillance Reference Group
AdvisoryBoardMember,MultipleSclerosisTrust:GeneratingEvidenceinMSServices
AdvisoryBoardMember,Evaluationoftheimpactoftobaccocontrolmassmediacampaignson quittingbehaviour,smokingprevalenceandsmoking-relatedhealthoutcomes
BoardMember,GlasgowCentreforPopulationHealth
DatamonitoringCommittee2011-2015:NIHRPacesTrial
NationalHealthEconomistsInterestGroup
Jim Lewsey CharteredStatistician,RoyalStatisticalSociety
CharteredScientist,TheScienceCouncil
MemberofEvidenceReviewCommitteeforScottishHealthTechnologiesGroup/Healthcare ImprovementScotland
Kathleen Boyd AdvisoryBoardMember,BeatsonWestofScotlandCancerCareClinicalTrialsUnit:In-houseTrials
Advisory Board
Neil Hawkins MemberofMedicalSectionCommitteeoftheRoyalStatisticalSociety
Olivia Wu Member of the NIHR Systematic Reviews Programme Advisory Group
Member of the NIHR HTA Evidence Synthesis Board
MemberoftheNationalInstituteofHealthandCareExcellenceTechnologyAppraisalCommittee
41
Health Economics and Health Technology Assessment (HEHTA)InstituteofHealth&Wellbeing
UniversityofGlasgow 1LilybankGardens,GlasgowG128RZ
Telephone:01413304010 www.gla.ac.uk/hehta
Email:[email protected] Twitter:@HEHTAGlasgow
©UniversityofGlasgow2017 ProducedanddesignedbyMVLSDesignandCommunication,UniversityofGlasgow
TheUniversityofGlasgow,charitynumberSC004401